BioHarvest Sciences partners with Saffron Tech to advance high-value botanical nutraceuticals

Proactive - Interviews for investors

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to announce a significant milestone — a strategic Contract Development and Manufacturing Organization agreement with Saffron Tech, an agritech leader pioneering advanced and scalable saffron cultivation. The collaboration is focused on developing and commercializing saffron-derived botanical compounds using BioHarvest’s patented Botanical Synthesis™ platform. Under the partnership structure, Saffron Tech will own 75% of any newly developed saffron compositions and their associated IP and commercialization rights, while BioHarvest will retain a 25% stake. Sobel explained that once development is completed, BioHarvest plans to leverage its large-scale production capabilities to manufacture the compound for a new line of saffron-based nutraceutical products, sold directly through its consumer channels. These formulations will aim to harness saffron’s well-established functional benefits, including support for cognitive performance, eye health, mood balance, and antioxidant activity. Saffron Tech brings a groundbreaking production model to the partnership. It is the first company to successfully produce multiple cycles of premium-grade saffron year-round, rather than relying on traditional seasonal farming. This innovation is especially impactful given saffron’s market dynamics — it is widely known as the world’s most expensive spice, commonly priced above $10,000 per kilogram due to high labor intensity and limited global supply, with Iran accounting for more than 80% of current production. Alongside the partnership announcement, Sobel provided a business update, reporting preliminary unaudited Q3 2025 revenue guidance of approximately $9.1 million, aligned with management expectations. Unaudited adjusted EBITDA is projected between ($0.7M) and ($0.4M) for the quarter, while cash and cash equivalents as of September 30, 2025 total approximately $11 million, supporting continued operational and commercialization progress. Sobel emphasized that the collaboration with Saffron Tech marks an exciting entry into a new, high-value market segment and further demonstrates BioHarvest’s ability to apply its Botanical Synthesis™ technology to multiple natural compounds with strong consumer demand and health-driven applications. #proactivinvestors #nasdaq #bhst #pharma #biotech #hearthealth #BioHarvestSciences, #IlanSobel, #Vinia #SportsNutrition #Resveratrol #InformedSport #AthleteWellness #FunctionalFoods #DailySupplements #BloodFlowSupport #HydrationMarket #PlantBasedInnovation #SaffronTech #SuperSaffron #BotanicalSynthesis #Nutraceuticals